Qsemble Capital Management, LP Bridge Bio Pharma, Inc. Transaction History
Qsemble Capital Management, LP
- $1.02 Trillion
- Q3 2025
A detailed history of Qsemble Capital Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Qsemble Capital Management, LP holds 55,320 shares of BBIO stock, worth $3.67 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
55,320
Previous 42,345
30.64%
Holding current value
$3.67 Million
Previous $1.83 Billion
57.14%
% of portfolio
0.28%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
446Shares Held
184MCall Options Held
11.3MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.12 Billion0.01% of portfolio
-
Viking Global Investors LP16MShares$1.06 Billion2.36% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$880 Million27.71% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$826 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X08.74MShares$580 Million0.22% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...